Evaluating the Safety Profile of Glucagon-Like Peptide-1 Receptor Agonists: Adverse Events and Clinical Recommendations

Mi Kyung Kim, Eun Yeong Ha, Hye Soon Kim

Open source

DOI
10.7570/jomes25081
Published
2026-03-13
Container
Journal of Obesity & Metabolic Syndrome
Publisher
Korean Society for the Study of Obesity
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7570/jomes25081,
  title = {Evaluating the Safety Profile of Glucagon-Like Peptide-1 Receptor Agonists: Adverse Events and Clinical Recommendations},
  author = {Mi Kyung Kim and Eun Yeong Ha and Hye Soon Kim},
  year = {2026},
  journal = {Journal of Obesity \& Metabolic Syndrome},
  doi = {10.7570/jomes25081},
  url = {https://doi.org/10.7570/jomes25081}
}

RIS

TY  - JOUR
TI  - Evaluating the Safety Profile of Glucagon-Like Peptide-1 Receptor Agonists: Adverse Events and Clinical Recommendations
AU  - Mi Kyung Kim
AU  - Eun Yeong Ha
AU  - Hye Soon Kim
PY  - 2026
JO  - Journal of Obesity & Metabolic Syndrome
DO  - 10.7570/jomes25081
UR  - https://doi.org/10.7570/jomes25081
ER  - 

APA

Kim, M. K., Ha, E. Y., & Kim, H. S. (2026). Evaluating the Safety Profile of Glucagon-Like Peptide-1 Receptor Agonists: Adverse Events and Clinical Recommendations. Journal of Obesity & Metabolic Syndrome. https://doi.org/10.7570/jomes25081

Source records